Mycroft: We have not heard from you in quite awhile. I am sure your still out here somewhere. I would your take on this "Right to Try" Legislation and how this may effect Anavex and its lead compound Anave 2-73. Maybe it wont effect Anavex at all? Your insight/thoughts is always appreciated.
As others have stated, the "Right to Try" Legislation seems very promising. I wouldn't discount Anavex leaving that option open though I think orphan approval followed by off-label use is likely the golden path.
Apologies for the delay in response, when there is a lull in the science, I tend to focus on other real world investments.
I am still very long on AVXL and continue to hold my (rather overweight) position.